NPR | June 18, 2024
Listen to NPR’s interview with Jeffrey Iliff, PhD about the brain’s need to flush out waste products to stay healthy and fend off conditions like Alzheimer’s disease.
NPR | June 18, 2024
Listen to NPR’s interview with Jeffrey Iliff, PhD about the brain’s need to flush out waste products to stay healthy and fend off conditions like Alzheimer’s disease.
Lever Time, Episode 1 | June 14, 2024
Scott Graupensperger, PhD, joins the Lever Time podcast to talk about the recent growth in online gambling and how it has impacted society, sports, and fandom.
Health Day | June 14, 2024
Margaret Sibley, PhD, comments on news that a health care fraud case will likely worsen ongoing shortages of Adderall and other ADHD medication.
UW Medicine newsroom | June 10, 2024
New website, along with 24/7 service from the UW Psychiatry Consultation Line, will help emergency department clinicians reduce overdose deaths and address drug addiction.
Right as Rain | June 10, 2024
Research by Mark Stein, PhD, who focuses on ADHD treatment, says that individuals with ADHD are at a much higher risk for marital conflicts and divorce.
Columbia Basin Herald | June 7, 2024
Among other things, the new ScalaNW program provides 24/7 clinical consultations through the expanded UW Psychiatry Consultation Line to ensure caregivers have everything they need to prescribe medication for opioid use disorder.
UW Medicine newsroom | June 7, 2024
Researchers, including Jesse Fann, MD, MPH have found that a collaborative care approach to pain treatment can significantly reduce chronic symptoms in patients with TBI.
Washington State Standard | June 6, 2024
A model credited to Caleb Banta-Green, PhD, MPH, MSW, and others provides a walk-in, “one-stop shop” for substance-use disorder patients. US Sen. Maria Cantwell is championing it in Congress.
Right as Rain | June 5, 2024
Julia Brechbiel, PhD, talks about how the traditional five stages of grief are great if they resonate with an individual, but grief doesn’t always have a linear or finite trajectory.
Seattle Met | May 30, 2024
Nathan Sackett, MD, MS, is heading up a study to explore the potential therapeutic value of psilocybin, the psychedelic compound found in mushrooms.